- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 33.4059 ↓ -1.02%
[as on 27 March, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 27 March, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | -5.43% | -1.02% | -0.79% | -5.2% | -5.71% | 1.24% | 23.69% | 16.37% | 19.96% | 13.19% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -12.96% | -2.07% | -1.09% | -8.7% | -13.09% | -8.96% | 11.62% | 15.36% | 13.63% | 14.88% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -12.61% | -2.24% | -0.95% | -10.59% | -12.07% | -3.46% | 12.26% | 10.75% | 11.9% | 12.42% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 0.78% | 1.53% | 0.74% | -1.67% | 0.39% | 2.66% | 27.04% | 18.94% | 21.36% | 13.22% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -10.47% | -2.07% | -2.16% | -9.51% | -9.75% | -2.8% | 18.56% | 19.21% | 17.71% | 16.19% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | -2.2% | -1.52% | -2.43% | -10.51% | -0.18% | 11.92% | 32.82% | 27.41% | 19.26% | 15.9% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | -12.74% | 5.85% | -0.68% | 7.04% | 67.87% | 19.94% | -6.85% | 39.53% | 42.49% | -3.93% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|
| Returns | -0.37% | 3.4% | 3.88% | -0.49% | -1.25% | 1.74% | 0.22% | -1.64% | -5.6% | 4.93% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 12.65% | -4.44% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.47% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.53% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.59% |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.13% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 4.96% |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.90% |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 4.71% |
| TORRENT PHARMACEUTICALS LTD | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.52% |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 4.42% |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 4.02% |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.92% |
| IPCA LABORATORIES LTD | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.56% |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 3.35% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 3.30% |
| ASTER DM HEALTHCARE LTD | ASTERDM (INE914M01019) | Healthcare Services | 3.29% |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.26% |
| J.B.CHEMICALS & PHARMACEUTICALS LTD | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 3.22% |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 3.18% |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 2.93% |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.89% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.63% |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 2.33% |
| GLENMARK PHARMACEUTICALS LTD | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.17% |
| PI INDUSTRIES LTD | PIIND (INE603J01030) | Fertilizers & Agrochemicals | 2.17% |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.09% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | KIMS (INE967H01025) | Healthcare Services | 2.01% |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 1.76% |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.63% |
| COHANCE LIFESCIENCES LTD | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 1.51% |
| VIJAYA DIAGNOSTIC CENTRE LTD | VIJAYA (INE043W01024) | Healthcare Services | 1.50% |
| WOCKHARDT LTD | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.41% |
| AKUMS DRUGS AND PHARMACEUTICALS LTD | AKUMS (INE09XN01023) | Pharmaceuticals & Biotechnology | 0.89% |
| HIKAL LTD | HIKAL (INE475B01022) | Pharmaceuticals & Biotechnology | 0.71% |
| PFIZER LTD | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 0.42% |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.06% |
| LAXMI DENTAL LTD | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.03% |
Portfolio data is as on date 31 October, 2025
NAV history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 27 March, 2026 | 33.4059 | -1.02% |
| 25 March, 2026 | 33.7488 | 1.41% |
| 24 March, 2026 | 33.2806 | 1.29% |
| 23 March, 2026 | 32.8577 | -2.42% |
| 20 March, 2026 | 33.6709 | 0.8% |
| 19 March, 2026 | 33.4038 | -2.1% |
| 18 March, 2026 | 34.1218 | 0.56% |
| 17 March, 2026 | 33.9323 | 0.27% |
| 16 March, 2026 | 33.8397 | -0.87% |
| 13 March, 2026 | 34.1358 | -1.76% |
| 12 March, 2026 | 34.7472 | -0.91% |
| 11 March, 2026 | 35.0656 | 0.09% |
| 10 March, 2026 | 35.0327 | 0.94% |
| 9 March, 2026 | 34.7054 | -0.52% |
| 6 March, 2026 | 34.8879 | -0.21% |
| 5 March, 2026 | 34.9609 | 0.53% |
| 4 March, 2026 | 34.7762 | -0.95% |
| 2 March, 2026 | 35.1092 | -0.37% |
| 27 February, 2026 | 35.2393 | -0.85% |
| 26 February, 2026 | 35.5404 | 0.65% |
| 25 February, 2026 | 35.3120 | 0.79% |
| 24 February, 2026 | 35.0341 | -0.43% |
| 23 February, 2026 | 35.1843 | 1.05% |
| 20 February, 2026 | 34.8174 | -0.06% |
| 19 February, 2026 | 34.8399 | -0.56% |
| 18 February, 2026 | 35.0369 | 0.3% |
| 17 February, 2026 | 34.9333 | 0.6% |
| 16 February, 2026 | 34.7262 | 0.48% |
| 13 February, 2026 | 34.5599 | -1.14% |
| 12 February, 2026 | 34.9589 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 33.4059 as on 27 March, 2026.
What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are -5.43% as on 27 March, 2026.
What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 1.24% as on 27 March, 2026.
What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 23.69% as on 27 March, 2026.
What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 16.37% as on 27 March, 2026.
What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 16.37% as on 27 March, 2026.
